GC
SPPI

Guggenheim Capital’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Guggenheim Capital’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-168,956
Closed -$1.46M – 2170
2019
Q2 		$1.46M Buy
168,956
+1,272
+0.8% +$11.4K 0.01% 1181
2019
Q1 		$1.79M Buy
167,684
+12,179
+8% +$130K 0.01% 1120
2018
Q4 		$1.36M Buy
155,505
+22,191
+17% +$283K 0.01% 1234
2018
Q3 		$2.24M Sell
133,314
-1,781
-1% -$38.5K 0.01% 1182
2018
Q2 		$2.83M Buy
135,095
+4,868
+4% +$90.2K 0.02% 1043
2018
Q1 		$2.1M Sell
130,227
-1,687
-1% -$33.4K 0.01% 1600
2017
Q4 		$2.5M Buy
+131,914
New +$2.39M 0.01% 1503
2017
Q3 		– Sell
-11,567
Closed -$88K – 2863
2017
Q2 		$88K Buy
11,567
+775
+7% +$5.06K ﹤0.01% 2703
2017
Q1 		$69K Sell
10,792
-4,354
-29% -$24.3K ﹤0.01% 2715
2016
Q4 		$67K Buy
15,146
+1,068
+8% +$4.48K ﹤0.01% 2789
2016
Q3 		$66K Buy
14,078
+2,419
+21% +$14.3K ﹤0.01% 2756
2016
Q2 		$77K Sell
11,659
-491
-4% -$3.47K ﹤0.01% 2753
2016
Q1 		$77K Buy
+12,150
New +$62.3K ﹤0.01% 2778
2014
Q1 		– Sell
-265,436
Closed -$2.35M – 3378
2013
Q4 		$2.35M Sell
265,436
-68,539
-21% -$612K 0.01% 1634
2013
Q3 		$2.8M Buy
333,975
+62,241
+23% +$504K 0.01% 1397
2013
Q2 		$2.03M Buy
+271,734
New +$2.08M 0.01% 1516

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Guggenheim Capital's SPPI Position: Q3 2019 in Review

Guggenheim Capital sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2019, closing a stake of 168,956 shares — an estimated $1.46M sold.

Guggenheim Capital first reported a position in SPPI in Q2 2013 and held it in 16 quarters. The position peaked at $2.83M in Q2 2018. 167 funds tracked by Wall St. Rank hold SPPI as of Q3 2019.

  • Guggenheim Capital reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2019 after selling out during the quarter.
  • Guggenheim Capital sold 168,956 Spectrum Pharmaceuticals Inc shares in Q3 2019, an estimated $1.46M.
  • Guggenheim Capital first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 16 quarters.
  • Guggenheim Capital's Spectrum Pharmaceuticals Inc position peaked at $2.83M in Q2 2018.
  • 167 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2019.

Based on Guggenheim Capital's 13F filing for Q3 2019, filed 14 Nov 2019.